Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Observation

Novel Type III Effectors in Pseudomonas aeruginosa

David Burstein, Shirley Satanower, Michal Simovitch, Yana Belnik, Meital Zehavi, Gal Yerushalmi, Shay Ben-Aroya, Tal Pupko, Ehud Banin
Stephen Carlyle Winans, Editor
David Burstein
aDepartment of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shirley Satanower
bThe Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
cThe Institute for Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michal Simovitch
bThe Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
cThe Institute for Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yana Belnik
bThe Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
cThe Institute for Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meital Zehavi
bThe Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
cThe Institute for Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gal Yerushalmi
bThe Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
cThe Institute for Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shay Ben-Aroya
bThe Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tal Pupko
aDepartment of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ehud Banin
bThe Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
cThe Institute for Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Carlyle Winans
Cornell University
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.00161-15
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Supplemental Material
  • Additional Files
  • FIG 1 
    • Open in new tab
    • Download powerpoint
    FIG 1 

    (a) Two new putative effectors are translocated into HeLa cells. (Top row) HeLa cells were infected with Δ3tox strains (active T3SS) or Δ3tox ΔpscJ strains (nonactive T3SS) expressing either unfused BlaM, ExoS, or two putative effectors (PemA and PemB) fused to BlaM. Cells stained in blue indicate successful translocation of BlaM fused to the bacterial effector. Green cells indicate no translocation (×10 magnification). (b) The two new effectors are not essential structural components of the T3SS machinery. HeLa cells were infected with a P. aeruginosa strain lacking the known effectors (Δ3tox), a strain which has a nonfunctional T3SS (Δ3tox ΔpscJ), or strains with deletions of the putative genes pemA, pemB, or both (Δ3tox ΔpemA, Δ3tox ΔpemB, or Δ3tox ΔpemA ΔpemB) expressing ExoY fused to BlaM. Cells stained in blue indicate successful translocation of BlaM fused to the bacterial effector. Green cells indicate no translocation (×20 magnification).

  • FIG 2 
    • Open in new tab
    • Download powerpoint
    FIG 2 

    (a) The two new effectors are not cytotoxic to HeLa cells. HeLa cells were infected with wild-type P. aeruginosa or the Δ3tox or Δ3tox ΔpscJ strain and three strains lacking one (Δ3tox ΔpemA or Δ3tox ΔpemB) or both (Δ3tox ΔpemA ΔpemB) of the newly discovered effectors. Cytotoxicity was assessed by the CytoTox-ONE homogeneous membrane integrity assay after 4 h of infection. Three biological repeats were performed in duplicate. Expression of the effectors under these conditions was validated (see Fig. S5A in the supplemental material). None of the strains showed a significant change in cytotoxicity according to the one-way analysis of variance (ANOVA) test. (b) Expression of the two new effectors does not affect the growth of S. cerevisiae. pemA and pemB were expressed from the GAL10 promoter in S. cerevisiae BY4741. Growth was assessed by a yeast spotting assay. One molar sorbitol, 7 mM caffeine, 0.5 M NaCl, 0.12 µg/ml tunicamycin, and growth at 37°C were used to assess the growth effects of the effectors under various stress conditions. S. cerevisiae expressing the Legionella toxic effector lpg2975 and the empty vector pGREG523-Km were used as controls. Three biological repeats were performed. Effector expression was validated by Western blotting (Fig. S6B).

Supplemental Material

  • Figures
  • Additional Files
  • Figure S1 

    Machine learning classification scheme. Download Figure S1, DOCX file, 0.3 MB.

    Copyright © 2015 Burstein et al.

    This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Table S1 

    Positive machine-learning training-set and list of features used for the machine learning. Table S1, DOCX file, 0.04 MB.

    Copyright © 2015 Burstein et al.

    This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Table S2 

    Top 12 predicted effectors. Table S2, DOCX file, 0.01 MB.

    Copyright © 2015 Burstein et al.

    This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Figure S2 

    Translocation results of predicted effectors. Download Figure S2, DOCX file, 0.6 MB.

    Copyright © 2015 Burstein et al.

    This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Figure S3 

    Alignments of PemA and PemB homologs from the Pseudomonas genus. Download Figure S3, PDF file, 0.8 MB.

    Copyright © 2015 Burstein et al.

    This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Table S3 

    Distribution of T3SS genes among different Pseudomonas aeruginosa strains. Table S3, DOCX file, 0.02 MB.

    Copyright © 2015 Burstein et al.

    This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Figure S4 

    Effector ExsA binding site in P. aeruginosa PA14. Download Figure S4, DOCX file, 0.1 MB.

    Copyright © 2015 Burstein et al.

    This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Figure S6 

    Overexpressed pemA and pemB are not cytotoxic to HeLa cells. Download Figure S6, DOCX file, 0.03 MB.

    Copyright © 2015 Burstein et al.

    This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Figure S5 

    Verification of expression of the effectors. Download Figure S5, DOCX file, 1.1 MB.

    Copyright © 2015 Burstein et al.

    This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

  • Table S4 

    Strains, plasmids, and primers used in this study. Table S4, DOCX file, 0.03 MB.

    Copyright © 2015 Burstein et al.

    This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

Additional Files

  • Figures
  • Supplemental Material
  • Supplementary Data

    Supplementary Data

    Files in this Data Supplement:

    • Figure sf3, PDF - Figure sf3, PDF
    • Figure sf1, DOCX - Figure sf1, DOCX
    • Figure sf2, DOCX - Figure sf2, DOCX
    • Figure sf4, DOCX - Figure sf4, DOCX
    • Figure sf5, DOCX - Figure sf5, DOCX
    • Figure sf6, DOCX - Figure sf6, DOCX
    • Table st1, DOCX - Table st1, DOCX
    • Table st2, DOCX - Table st2, DOCX
    • Table st3, DOCX - Table st3, DOCX
    • Table st4, DOCX - Table st4, DOCX
PreviousNext
Back to top
Download PDF
Citation Tools
Novel Type III Effectors in Pseudomonas aeruginosa
David Burstein, Shirley Satanower, Michal Simovitch, Yana Belnik, Meital Zehavi, Gal Yerushalmi, Shay Ben-Aroya, Tal Pupko, Ehud Banin
mBio Mar 2015, 6 (2) e00161-15; DOI: 10.1128/mBio.00161-15

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Novel Type III Effectors in Pseudomonas aeruginosa
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Novel Type III Effectors in Pseudomonas aeruginosa
David Burstein, Shirley Satanower, Michal Simovitch, Yana Belnik, Meital Zehavi, Gal Yerushalmi, Shay Ben-Aroya, Tal Pupko, Ehud Banin
mBio Mar 2015, 6 (2) e00161-15; DOI: 10.1128/mBio.00161-15
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • Observation
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511